TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
BioBag International AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
51,974
|
503,660
|
432,329 |
| Financial expenses |
22,428
|
1,712
|
21,559 |
| Earnings before taxes |
4,562
|
6,592
|
15,644 |
| Total assets |
92,532
|
250,370
|
222,848 |
| Current assets |
25,892
|
171,924
|
146,599 |
| Current liabilities |
33,344
|
109,415
|
82,208 |
| Equity capital |
59,189
|
118,385
|
105,995 |
| - share capital |
3,519
|
3,769
|
3,656 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
64.0%
|
47.3%
|
47.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
8.8%
|
1.3%
|
3.6% |
| Return on assets (ROA) |
29.2%
|
3.3%
|
16.7% |
| Current ratio |
77.7%
|
157.1%
|
178.3% |
| Return on equity (ROE) |
7.7%
|
5.6%
|
14.8% |
| Change turnover | |||
| Change turnover % |
13%
|
-8% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.